Healthcare Realty Trust Incorpo
HR Mid CapReal Estate · REIT - Healthcare Facilities
Mis à jour: Jun 23, 2026, 22:21 UTC
Price Chart
Indicateurs clés
Valuation Analysis
About the Company
Healthcare Realty Trust Incorpo en bref
Healthcare Realty Trust Incorpo (HR) is currently trading at 17,83 € with a market capitalization of 6,3 Md €. The 52-week range spans from 13,38 € to 18,36 €; the current price is 2.9% below the yearly high. Year-over-year revenue growth stands at -6.5%.
💰 Dividende
Healthcare Realty Trust Incorpo pays an annual dividend of 0,84 € per share, representing a yield of 4.73%. The payout ratio stands at 251.53%. The elevated payout ratio reflects a mature dividend policy.
📊 Avis des analystes
12 analystes évaluent Healthcare Realty Trust Incorpo (HR) au consensus : Acheter. L'objectif de cours moyen est de 18,52 €, soit un potentiel de +3.86% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 15,81 € à 21,08 €.
Healthcare Realty Trust Incorpo : la thèse d'investissement en détail
Healthcare Realty Trust Incorpo (HR) operates in the Real Estate — specifically REIT - Healthcare Facilities — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.
Le scénario haussier
With a gross margin near 61.99%, the company sits in the top tier of its industry — these are the kinds of structural margins that protect earnings during downturns.
Le scénario baissier
Revenue is contracting at -6.5% year-over-year — until that trend reverses, valuation is exposed to further downgrades. Net margins remain negative, meaning every euro of revenue is still producing losses — the path to profitability is the central question for shareholders.
Valorisation en contexte
At a PEG of 8.82, investors are paying more than three times the growth rate for each unit of earnings — that pricing assumes growth not only continues but accelerates from here.
Thèse d'investissement : forces et faiblesses
- Marge brute élevée de 61.99% — signe d'un pouvoir de fixation des prix
- Consensus des analystes : Buy
- Rendement du dividende solide de 4.73%
- Free cash flow positif
- –CA en contraction (-6.5% sur un an)
- –Actuellement non rentable
Aperçu technique
Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).
Profil de risque
The data points to relatively defensive market behavior, elevated short interest (8.47%).
Trading Data
💵 Dividend Info
Related Stocks in the Same Sector
More Immobilier stocks
Top peers in the same sector — ranked by market cap.
Where can I buy Healthcare Realty Trust Incorpo?
Compare top-rated brokers — low fees, trusted providers, fully regulated.
Live Market Data
Real-time chart, financials, earnings, analysts, insider trades, events & news
